Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UK's NICE Recommends Boston Scientific’s Rezum Steam Treatment For BPH

Executive Summary

The UK’s NICE has recommended the use of Boston Scientific’s Rezum system for treatment of enlarged prostate. The minimally invasive procedure involves injecting steam to destroy excess prostate tissue.

You may also be interested in...



UK's NICE Backs Funding For Olympus Plasma System For BPH

The bipolar electrosurgery Plasma system reduces the risks associated with conventual monopolar transurethral resection of the prostate and works out cheaper, according to health technology assessment body NICE.

Boston Scientific Remains On Track For Return To Growth By 2021

The company’s sales declined 29% in the second quarter of 2020 due to the pandemic, but sales trends indicate the start of a worldwide recovery across all of Boston Scientific’s businesses.

M&A Analysis – Deals March On In Big Month For Boston Scientific

Medtech Insight recorded 17 merger or acquisition deals in March, a rise from the nine deals recorded last month and in the same period last year. It was a busy month for Boston Scientific, which racked up two acquisitions, paying $460m for urology device maker NxThera and an undisclosed price for endoscopy firm EMcision.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT142351

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel